Search Results - "Hlatky, Mark"

Increasing value and reducing waste in research design, conduct, and analysis by Ioannidis, John P A, Prof, Greenland, Sander, Prof, Hlatky, Mark A, Prof, Khoury, Muin J, MD, Macleod, Malcolm R, Prof, Moher, David, Prof, Schulz, Kenneth F, Prof, Tibshirani, Robert, Prof

“…Summary Correctable weaknesses in the design, conduct, and analysis of biomedical and public health research studies can produce misleading results and waste…”
Get full text

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association by Parikh, Nisha I., Gonzalez, Juan M., Anderson, Cheryl A.M., Judd, Suzanne E., Rexrode, Kathryn M., Hlatky, Mark A., Gunderson, Erica P., Stuart, Jennifer J., Vaidya, Dhananjay

“…This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes,…”
Get full text

Willingness to Pay for High-Cost Medications by Hlatky, Mark A.

Get full text

PCSK9 Inhibitors: Economics and Policy by Hlatky, Mark A, Kazi, Dhruv S

“…Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors substantially reduce low-density lipoprotein cholesterol, but it is presently unclear whether…”
Get full text

Economic value of multimodal cardiovascular screening by Hlatky, Mark A, Greenland, Philip

Get full text

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines by Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

Get full text

A Pound of Prevention? Assessing the Value of New Cholesterol-Lowering Drugs by Hlatky, Mark A

“…Hlatky discusses the assessment of the value of new cholesterol-lowering drugs. Although cardiovascular disease has been decreasing for decades, it remains the…”
Get full text

Association Between Age and Low-Density Lipoprotein Cholesterol Response to Statins : A Danish Nationwide Cohort Study by Corn, Giulia, Melbye, Mads, Hlatky, Mark A, Wohlfahrt, Jan, Lund, Marie

“…There is large patient-to-patient variability in the low-density lipoprotein cholesterol (LDL-C) response to statin treatment. The reduction in LDL-C may…”
Get full text

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines by Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

Get full text

Association of Coronary CT Angiography or Stress Testing With Subsequent Utilization and Spending Among Medicare Beneficiaries by Shreibati, Jacqueline Baras, Baker, Laurence C, Hlatky, Mark A

“…CONTEXT Coronary computed tomography angiography (CCTA) is a new noninvasive diagnostic test for coronary artery disease (CAD), but its association with…”
Get full text

Rheumatoid arthritis and cardiovascular disease by Crowson, Cynthia S., MS, Liao, Katherine P., MD, MPH, Davis, John M., MD, Solomon, Daniel H., MD, MPH, Matteson, Eric L., MD, MPH, Knutson, Keith L., PhD, Hlatky, Mark A., MD, Gabriel, Sherine E., MD, MSc

“…Background Rheumatic disease and heart disease share common underpinnings involving inflammation. The high levels of inflammation that characterize rheumatic…”
Get full text

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines by Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

“…Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines…”
Get full text

RESPONSE: A Mentor’s Perspective on Using Shared Research Data by Hlatky, Mark A.

“…The increased availability of shared data from clinical research studies provides great opportunities for fellows-in-training to ask interesting research…”
Get full text

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines by Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

“…Throughout these guidelines similar to the 2013 guidelines, consistent attention is given to a clinician–patient risk discussion for making shared decisions…”
Get full text

Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation by Shah, Rashmee U., MD, MS, Freeman, James V., MD, MPH, Shilane, David, PhD, Wang, Paul J., MD, Go, Alan S., MD, Hlatky, Mark A., MD

“…Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat…”
Get full text

Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) by Fearon, William F, Nishi, Takeshi, De Bruyne, Bernard, Boothroyd, Derek B, Barbato, Emanuele, Tonino, Pim, Jüni, Peter, Pijls, Nico H.J, Hlatky, Mark A

“…BACKGROUND:Previous studies found that percutaneous coronary intervention (PCI) does not improve outcome compared with medical therapy (MT) in patients with…”
Get full text

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines by Greenland, Philip, Alpert, Joseph S, Beller, George A, Benjamin, Emelia J, Budoff, Matthew J, Fayad, Zahi A, Foster, Elyse, Hlatky, Mark A, Hodgson, John McB, Kushner, Frederick G, Lauer, Michael S, Shaw, Leslee J, Smith, Jr, Sidney C, Taylor, Allen J, Weintraub, William S, Wenger, Nanette K, Jacobs, Alice K

Get full text

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review by Sarnak, Mark J, Amann, Kerstin, Bangalore, Sripal, Cavalcante, João L, Charytan, David M, Craig, Jonathan C, Gill, John S, Hlatky, Mark A, Jardine, Alan G, Landmesser, Ulf, Newby, L Kristin, Herzog, Charles A, Cheung, Michael, Wheeler, David C, Winkelmayer, Wolfgang C, Marwick, Thomas H

“…Chronic kidney disease (CKD) is a major risk factor for coronary artery disease (CAD). As well as their high prevalence of traditional CAD risk factors, such…”
Get full text

Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease by Parikh, Rushi V., Liu, Grace, Plomondon, Mary E., Sehested, Thomas S.G., Hlatky, Mark A., Waldo, Stephen W., Fearon, William F.

“…The use and clinical outcomes of fractional flow reserve (FFR) measurement in patients with stable ischemic heart disease (SIHD) are uncertain, as prior…”
Get full text

Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association by Rao, Goutham, Lopez-Jimenez, Francisco, Boyd, Jack, D’Amico, Frank, Durant, Nefertiti H, Hlatky, Mark A, Howard, George, Kirley, Katherine, Masi, Christopher, Powell-Wiley, Tiffany M, Solomonides, Anthony E, West, Colin P, Wessel, Jennifer

“…Meta-analyses are becoming increasingly popular, especially in the fields of cardiovascular disease prevention and treatment. They are often considered to be a…”
Get full text